Literature DB >> 20092102

A two-degree-of-freedom hip exoskeleton device for an immature animal model of exercise-induced Legg-Calvé-Perthes disease.

J F Zhang1, C J Yang, T Wu, J H Li, Z S Xu, Y Chen.   

Abstract

Legg-Calvé-Perthes disease (LCPD) is a significant problem in healthcare because it so commonly affects young adults and immature athletes, primarily gymnasts. In this paper, a two-degree-of-freedom (2-DOF) hip exoskeleton device was developed for study on an immature animal model of exercise-induced LCPD. The exoskeleton device can reproduce the repetitive actions and forceful centrality impingements on the coxafemoral head that occur in sports such as gymnastics and acrobatics. It initiated a new method rather than the traditional medical or physiological operation method to establish an animal model of LCPD and allowed for the development and testing of new treatments. Ten immature New Zealand white rabbits were selected for the experiment. Their right legs were driven to achieve repetitive extension/ flexion and abduction/adduction beyond the normal range of motion, with centrality impingements at the maximum flexion position, while their left legs were kept in the initial healthy status and acted as the comparing reference. Four weeks later, the basic symptoms of early LCPD of the femoral head appeared. The results of X-ray, magnetic resonance imaging (MRI), gross anatomy observation, and H-E section also revealed it.

Entities:  

Mesh:

Year:  2009        PMID: 20092102     DOI: 10.1243/09544119JEIM597

Source DB:  PubMed          Journal:  Proc Inst Mech Eng H        ISSN: 0954-4119            Impact factor:   1.617


  2 in total

1.  Ischial spine sign reveals acetabular retroversion in Legg-Calvé-Perthes disease.

Authors:  A Noelle Larson; Anthony A Stans; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2011-01-29       Impact factor: 4.176

Review 2.  Legg-Calvé-Perthes disease overview.

Authors:  Armando O Rodríguez-Olivas; Edgar Hernández-Zamora; Elba Reyes-Maldonado
Journal:  Orphanet J Rare Dis       Date:  2022-03-15       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.